Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda

Journal of Acquired Immune Deficiency Syndromes

Volumn 41, Issue 4, 2006, Pages 504-508

  Brahmbhatt, Heena ^a   Kigozi, Godfrey ^b   Wabwire Mangen, Fred ^c   Serwadda, David ^c   Lutalo, Tom ^b   Nalugoda, Fred ^b   Sewankambo, Nelson ^c   Kiduggavu, Mohamed ^b   Wawer, Maria ^d   Gray, Ronald ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^c MAKERERE UNIVERSITY   (Uganda)

^d Joseph L Mailman School of Public Health ^*  (United States)

Author keywords

CD4 count; Child mortality and HIV; HIV 1 viral load; Management of HIV infected children; Pediatric AIDS

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; CHILD; CHILDHOOD MORTALITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUERPERIUM; RURAL AREA; SURVIVAL; UGANDA; VERTICAL TRANSMISSION; VIRUS LOAD;

CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT MORTALITY; INFANT, NEWBORN; MULTIVARIATE ANALYSIS; PREGNANCY; RURAL POPULATION; STATISTICS; SURVIVAL ANALYSIS; UGANDA; VIRAL LOAD;

EID: 33646813668     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000188122.15493.0a     Document Type: Article

References (18)

1. UNAIDS/WHO. Global summary of the HIV/AIDS epidemic: December 2004. UNAIDS/WHO. 2004.
2. Newell ML, Coovadia H, Cortina-Borja M, et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet. 2004;364:1236-1243.
3. Dunn D. Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis. Lancet. 2003;362:1605-1611.
4. Department of Health and Human Services. Working Group on Antiretroviral Therapy and Medical Management of HIV Infected Children. Guidelines for the use of antiretroviral agents in pediatric HIV infection. 2004.
5. WHO. Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach. 2003.
6. Dunn D. Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis. Lancet. 2003;362:1605-1611.
7. Taha TE, Kumwenda NI, Broadhead RL, et al. Mortality after the first year of life among human immunodeficiency virus type 1-infected and uninfected children. Pediatr Infect Dis J. 1999;18:689-694.
8. Dabis F, Elenga N, Meda N, et al. 18-Month mortality and perinatal exposure to zidovudine in West Africa. AIDS. 2001;15:771-779.
9. Wawer MJ, Gray RH, Sewankambo NK, et al. A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS. 1998;12:1211-1225.
10. Gray RH, Wabwire-Mangen F, Kigozi G, et al. Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. Am J Obstet Gynecol. 2001;185:1209-1217.
11. Crampin AC, Floyd S, Glynn JR, et al. Long-term follow-up of HIV-positive and HIV-negative individuals in rural Malawi. AIDS. 2002;16: 1545-1550.
12. Statistics Department, Ministry of Finance and Economic Planning, Uganda. Uganda Demographic and Health Survey: 2000. Calverton, MD: Macro International; 2000.
13. Blanche S, Newell ML, Mayaux MJ, et al. Morbidity and mortality in European children vertically infected by HIV-1. The French Pediatric HIV Infection Study Group and European Collaborative Study. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:442-450.
14. Kuhn L, Thomas PA, Singh T, et al. Long-term survival of children with human immunodeficiency virus infection in New York City: estimates from population-based surveillance data. Am J Epidemiol. 1998;147:846-854.
15. Galli L, de Martino M, Tovo PA, et al. Predictive value of the HIV paediatric classification system for the long-term course of perinatally infected children. Int J Epidemiol. 2000;29:573-578.
16. Dunn D. Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis. Lancet. 2003;362:1605-1611.
17. Newell ML, Coovadia H, Cortina-Borja M, et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet. 2004;364:1236-1243.
18. Abrams EJ, Kuhn L. Should treatment be started among all HIV-infected children and then stopped? Lancet. 2003;362:1595-1596.